Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,828 | -7,880 | -7,634 | -10,173 | -12,615 |
| Depreciation Amortization | 24 | 7 | 15 | 14 | 14 |
| Accounts payable and accrued liabilities | 676 | 223 | -300 | -188 | 967 |
| Other Working Capital | 433 | -267 | -943 | -1,301 | 2,430 |
| Other Operating Activity | -254 | 280 | 422 | 847 | -654 |
| Operating Cash Flow | $-8,949 | $-7,637 | $-8,440 | $-10,801 | $-9,858 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,500 | 500 | 9,511 | -14,500 |
| PPE Investments | -2 | -5 | -2 | -9 | -11 |
| Investing Cash Flow | $-2 | $1,495 | $498 | $9,502 | $-14,511 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,644 | 6,711 | 9,144 | N/A | 20,457 |
| Financing Cash Flow | $9,644 | $6,711 | $9,144 | $N/A | $20,457 |
| Exchange Rate Effect | 10 | -22 | 98 | -113 | 34 |
| Beginning Cash Position | 4,825 | 4,278 | 2,978 | 4,390 | 8,268 |
| End Cash Position | 5,528 | 4,825 | 4,278 | 2,978 | 4,390 |
| Net Cash Flow | $703 | $547 | $1,300 | $-1,412 | $-3,878 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,949 | -7,637 | -8,440 | -10,801 | -9,858 |
| Capital Expenditure | -2 | -5 | -2 | -9 | -11 |
| Free Cash Flow | -8,951 | -7,642 | -8,442 | -10,810 | -9,869 |